Skip to main content

Want a detailed portfolio tracker?

INGN
NASDAQ
$6.40

Inogen Inc (INGN)

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.
Website: https://www.provider.inogen.com
68 analysts
Strong Buy
Target: $12.67 (+97.97%)

Market Cap

$175M

P/B Ratio

0.97

EPS 5Y CAGR

+32.49%

Free Cash Flow Yield

-2.02%

Price Chart

Valuation
Market Cap$175M
PEG3.48
P/S0.49
P/B0.97
Profitability
Total Revenue (TTM)$299M
Gross Profit (TTM)$156M
EBITDA-$12M
Profit Margin-11.5%
Operating Margin-12.9%
EPS-$0.91
Financial Health
Free Cash Flow Yield-2.02%
Growth & Risk
EPS 5Y CAGR+32.49%
Revenue 5Y CAGR+1.77%
Beta (5Y)0.85
Sharpe Ratio0.10